Portal de Periódicos da CAPES

“Piggy-Backing” on Diagnostic Platforms Brings Hope to Neglected Diseases: The Case of Sleeping Sickness

2010; Public Library of Science; Volume: 4; Issue: 5 Linguagem: Inglês

10.1371/journal.pntd.0000715

1935-2735

Joseph Mathu Ndung’u, Sylvain Biéler, Giorgio Roscigno,

CRISPR and Genetic Engineering

Neglected infectious diseases (NIDs) attract little interest from commercial companies that invest in diagnostics and therapeutics, mainly because the people that they affect are amongst the poorest in the world, who cannot afford to pay for them. Many commercial companies shy away from manufacturing diagnostic tests for NIDs because a return on investment is not usually guaranteed.